THIS NEW HOPE FOR WEIGHT MANAGEMENT ?

Scientists are increasingly investigating retatrutide, a promising treatment from Eli Lilly, as a potential step in body reduction . Different than many existing approaches, retatrutide is a twin-action receptor targeting equally GLP-1 and GIP, substances that affect hunger and glucose balance.